Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
MASAC Issues New and Updated Documents
 

The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) has issued the following new and updated documents, which were adopted by NHF’s Board of Directors on October 6, 2013:

 

MASAC Document #218
MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders (Revised October 2013)

 

MASAC Document #219
MASAC Resolution on Need to Facilitate Dialogue Between HTCs and Payers to Improve Access to Care at HTCs

 

MASAC Document #220
MASAC Recommendation Regarding Prophylaxis with Bypassing Agents in Patients with Hemophilia and High Titer Inhibitors

 

MASAC Document #221
MASAC Recommendations on Administration of Vaccines to Individuals with Bleeding Disorders

 

MASAC Document #222
MASAC Recommendations Regarding Physical Therapy Guidelines in Patients with Bleeding Disorders (Revised October 2013)

 

MASAC Document #223
MASAC Recommendations on Liver Biopsy in Individuals with Hemophilia

(Revised October 2013)

 

To view these documents, click the corresponding links above or review the complete list of current MASAC documents. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center: handi@hemophilia.org or 1.800.424.2634
 

This section of our Web site is sponsored by: